0 0 0
This online shop is using cookies to give you the best shopping experience. Thereby for example the session information or language setting are stored on your computer. Without cookies the range of the online shop's functionality is limited. If you don't agree, please click here.
Product 63 of 63

Figlin, Rathmell, Rini Renal Cell Carcinoma

Translational Biology Personalized Medicine and Novel Therapeutic Targets

ISBN: 978-1-4614-2399-7

Edition: 1st Ed.

Publication date: March 2012

Cover: Hardcover

Pages: 327 p.

Illustrations: 34 ill.

Publisher: Springer

Delivery times, dependent on availability and publisher: between 2 and 14 days from when you complete the order.

Description

  • Provides a comprehensive look at renal cell carcinoma
  • Explores renal cell carcinoma biology
  • Discusses future molecular targets for renal cancer carcinoma

This volume examines every major topic area in the modern era of renal carcinoma biology and treatment. The unique and intricate genetics of this cancer are highly distinct from most other tumors, and the advances made in this cancer beyond VHL biology have been intrinsically driven by discoveries from familial renal cell carcinomas linked with newer large scale genomic efforts in sporadic disease. These genetic findings fuel strategies to analyze and define sporadic tumors for greater accuracy in prognosis and prediction of response to therapy.

Additional topics include major new therapeutic strategies that harness these biological discoveries, in particular angiogenic, energy metabolism, chromatin remodeling, tumor microenvironment, and classical signaling pathways. This text will bring all of these avenues of investigation together for readers interested in understanding the dynamics of this field in the last decade and anticipating a continued steep trajectory in advancements toward the cure of this disease in its many manifestations.